Search results

Ethos slams Novartis for advisory vote on sustainability report at AGM

2024-02-16T10:30:00Z

‘There is no doubt’ that a binding vote is necessary, says foundation

Ethos opposes Novartis’ proposal of virtual-only AGMs

2023-02-21T14:46:00Z

The foundation is in favour instead of ‘hybrid’ AGMs

Swiss pension funds hit by Nestlé slump and equity home bias

2025-10-01T09:30:00Z

PPCmetrics shows that Swiss pension funds have invested CHF11bn – or 1.3% of total assets of CHF909bn – in Nestlé, more than any other single company

Swiss pension funds sail through index concentrations with positive returns

2026-01-21T09:30:00Z

Swiss pension funds recorded an average performance of 5.9% last year, corresponding to investment returns of CHF70bn, says Complementa

Swiss pension funds warned on equity, bond concentration risks

2025-09-08T09:00:00Z

‘Portfolio diversification remains the cornerstone of any investment strategy,’ says PPCmetrics

Swiss 1e pension plans spark appetite for younger generations

2020-08-21T14:43:00Z

Large companies with 1e solutions include CS and Novartis

Switzerland’s Ethos Foundation gets tough on governance

January/February 2026 (Magazine)

Sophie Robinson-Tillett interviews the Ethos Foundation’s Vincent Kaufmann

Novartis misses benchmark

2007-05-30T16:02:55Z

SWITZERLAND – Novartis’ CHF14.3bn (€8.7bn) pension fund has reported a return of just 2% for 2006 – below both the 6.6% average for other Swiss schemes and its own 3% benchmark.

Switzerland's Ethos presses for review of Novartis' remuneration policy

2011-02-22T15:15:00Z

Foundation argued that remuneration should not reward risk-taking.

Ethos plans Novartis revolt

2007-02-21T16:36:57Z

SWITZERLAND – Socially-responsible manager Ethos says it will oppose the re-election of a senior official at the Swiss pharmaceuticals giant Novartis during the firm’s annual shareholder meeting on March 6.

Oxfam starts Novartis campaign

2007-01-23T16:53:29Z

UK – Responsible investment campaigners FairPensions and international development agency Oxfam, have asked institutional investors to use their shareholder rights to put pressure on pharmaceutical firms.

Ethos finds shortfalls in Nestlé’s sustainability report

2024-04-05T10:00:00Z

The company is failing to disclose sufficient detail in particular on Scope 3 emissions

New head at €8bn Novartis scheme

2006-10-10T16:11:56Z

SWITZERLAND – Gino Pfister has stepped down as director of the Novartis pension fund, one of Switzerland’s biggest with CHF14.6bn (€8.6bn) in assets.

​Swedish pension funds warn companies against digital-only AGMs

2024-02-20T09:00:00Z

Alecta, AMF, AP funds say will vote down proposals to axe obligation to hold physical shareholder meetings

Novartis pension fund returns 6.2%

2006-06-02T03:39:00Z

SWITZERLAND – Novartis’ pension fund, one of Switzerland’s biggest with CHF14.6bn (€9.3bn) in assets, has reported a return of 6.2% for 2005 - well below the 11% average for other Swiss schemes.

Novartis shifts from 'bricks and mortar'

December 2002 (Magazine)

The SFr16.8bn (e11.4bn) pension scheme of Swiss pharmaceutical giant, Novartis, holds real estate assets that comprise 12% of the fund’s assets. Earlier this year, it completed a major transition in the approach to its property portfolio, which allowed the fund to maintain its exposure to this asset class, while enabling ...

Large Swiss firms fail to assess impact of digital transformation on workforce

2023-12-19T14:46:00Z

However, Switzerland’s largest listed companies researched in Ethos study have improved their scores with regard to digital responsibly

Novartis ready for the euro

May 1998 (Magazine)

Novartis fund makes move from concrete to paper

January 2002 (Magazine)

Pension funds in Switzerland have a long tradition of investing in property, and the team responsible for the Sfr18bn(e12bn) Novartis pension fund is not exception. The Basle-based pension fund has for years had a significant exposure to real estate, around 12% of the total portfolio, through direct holdings in property, ...

Novartis fund sells property in strategy shift

2001-10-02T04:37:00Z

SWITZERLAND – The SFr17.5bn pension fund of pharmaceutical giant Novartis, has sold around 100 buildings in its property portfolio to Credit Suisse Asset Management (CSAM) in a change of strategy that will see the fund concentrate its real estate portfolio on indirect investment through Credit Suisse....